Table 8.
Outcome of patients.
| Total | No (%) |
|---|---|
| 213 (100%) | |
| Survival per months (Mean ± SD) (Range) | 30.7 ± 31.2 (0–134) |
| All recepients | |
| 6-month survival | 139/213 (65.3%) |
| 1-year survival | 131/213 (61.5%) |
| 3-year survival | 119/213 (55.9%) |
| 5-year survival | 118/213 (55.4%) |
| 7-year survival | 116/213 (54.5%) |
| 10-year survival | 116/213 (54.5%) |
| HA and/or PV complication | |
| 6-month survival | 23/42 (54.8%) |
| 1-year survival | 18/42 (42.9%) |
| 3-year survival | 16/42 (38.1%) |
| 5-year survival | 16/42 (38.1%) |
| 7-year survival | 16/42 (38.1%) |
| 10-year survival | 16/42 (38.15) |
| No complications | |
| 6-month survival | 116/171 (67.8%) |
| 1-year survival | 113/171 (66.1%) |
| 3-year survival | 103/171 (60.2%) |
| 5-year survival | 102/171 (59.6%) |
| 7-year survival | 100/171 (58.5%) |
| 10-year survival | 100/171 (58.5%) |
| Adults | |
| 6-month survival | 123/186 (66.1%) |
| Overall survival | 103/186 (55.4%) |
| Pediatrics | |
| 6-month survival | 16/27 (59.3%) |
| Overall survival | 13/27 (48.1%) |
| Graft survival | 114/213 (53.5%) |
| Mortality in all patients | 97/213 (45.5%) |
| Mortality in patients with HA and/or PV complication | 26/42 (61.9%) |
| Mortality directly related to HA and/or PV complication | 13/42 (31%) |
| Causes | |
| PVT | 6/42 (14.3%) |
| Iatrogenic bleeding | 4/42 (9.5%) |
| HAT | 3/42 (7.1%) |